Mechanism for leptin's acute insulin-independent effect to reverse diabetic ketoacidosis

Journal of Clinical Investigation

Volumn 127, Issue 2, 2017, Pages 657-669

  Perry, Rachel J ^a   Peng, Liang ^a   Abulizi, Abudukadier ^a   Kennedy, Lynn ^a   Cline, Gary W ^a   Shulman, Gerald I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; CORTICOSTERONE; GLUCAGON; GLUCOSE; INSULIN; LEPTIN; STREPTOZOCIN; TRIACYLGLYCEROL LIPASE; DIACYLGLYCEROL; TRIACYLGLYCEROL;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIABETIC KETOACIDOSIS; ENDOCRINE DISEASE; FOOD INTAKE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HYPERCORTICOSTERONEMIA; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULIN BLOOD LEVEL; KETOGENESIS; LIPOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SUBSTITUTION THERAPY; ANIMAL; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; MOUSE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC KETOACIDOSIS; DIGLYCERIDES; INSULIN; LEPTIN; LIPOLYSIS; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 85014128257     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI88477     Document Type: Article

References (32)

1. Yu X, Park BH, Wang MY, Wang ZV, Unger RH. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci U S A. 2008;105(37):14070-14075.
2. Fujikawa T, Chuang JC, Sakata I, Ramadori G, Coppari R. Leptin therapy improves insulindeficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci U S A. 2010;107(40):17391-17396.
3. Hidaka S, et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J. 2002;16(6):509-518.
4. Lin CY, Higginbotham DA, Judd RL, White BD. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2002;282(5):E1084-E1091.
5. Fujikawa T, et al. Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin. Cell Metab. 2013;18(3):431-444.
6. Meek TH, et al. Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia. Endocrinology. 2013;154(9):3067-3076.
7. Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes. 1999;48(7):1487-1492.
8. Wang MY, et al. Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A. 2010;107(11):4813-4819.
9. Park JY, et al. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: The effect of long-term leptin therapy. J Clin Endocrinol Metab. 2008;93(1):26-31.
10. Xu Y, Chang JT, Myers MG, Xu Y, Tong Q. Euglycemia restoration by central leptin in type 1 diabetes requires STAT3 signaling but not fast-acting neurotransmitter release. Diabetes. 2016;65(4):1040-1049.
11. Foster DW. Malonyl-CoA: The regulator of fatty acid synthesis and oxidation. J Clin Invest. 2012;122(6):1958-1959.
12. Perry RJ, et al. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Med. 2014;20(7):759-763.
13. Morton GJ, Meek TH, Matsen ME, Schwartz MW. Evidence against hypothalamic-pituitary-adrenal axis suppression in the antidiabetic action of leptin. J Clin Invest. 2015;125(12):4587-4591.
14. Mayer N, et al. Development of small-molecule inhibitors targeting adipose triglyceride lipase. Nat Chem Biol. 2013;9(12):785-787.
15. Perry RJ, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160(4):745-758.
16. McGarry JD, Mannaerts GP, Foster DW. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest. 1977;60(1):265-270.
17. Perry RJ, Lee S, Ma L, Zhang D, Schlessinger J, Shulman GI. FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic-pituitaryadrenal axis. Nat Commun. 2015;6:6980.
18. Petersen KF, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109(10):1345-1350.
19. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014;371(12):1131-1141.
20. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126(1):12-22.
21. Petersen MC, et al. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. J Clin Invest. 2016;126(11):4361-4371.
22. Ruud J, Brüning JC. Metabolism: Light on leptin link to lipolysis. Nature. 2015;527(7576):43-44.
23. Cummings BP, et al. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats. Proc Natl Acad Sci U S A. 2011;108(35):14670-14675.
24. Denroche HC, et al. Leptin therapy reverses hyperglycemia in mice with streptozotocininduced diabetes, independent of hepatic leptin signaling. Diabetes. 2011;60(5):1414-1423.
25. Kim GH, Szabo A, King EM, Ayala J, Ayala JE, Altarejos JY. Leptin recruits Creb-regulated transcriptional coactivator 1 to improve hyperglycemia in insulin-deficient diabetes. Mol Metab. 2015;4(3):227-236.
26. Rossetti L, Shulman GI, Zawalich W, DeFronzo RA. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest. 1987;80(4):1037-1044.
27. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest. 1987;79(5):1510-1515.
28. Layman DK, Wolfe RR. Sample site selection for tracer studies applying a unidirectional circulatory approach. Am J Physiol. 1987;253(2 Pt 1):E173-E178.
29. Katz J. On the determination of turnover in vivo with tracers. Am J Physiol. 1992; 263(3 Pt 1):E417-E424.
30. Katz J, Okajima F, Chenoweth M, Dunn A. The determination of lactate turnover in vivo with 3H-and 14C-labelled lactate. The significance of sites of tracer administration and sampling. Biochem J. 1981;194(2):513-524.
31. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911-917.
32. Yu C, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;277(52):50230-50236.